The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.
"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
The Chosun Ilbo on MSN
Silicon Valley's biological age obsession sparks scientific debate
Recently, ‘biological age’ tests have been gaining popularity in Silicon Valley, the United States. These tests measure ...
"CGIE™ is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory —the ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced the ...
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback